BLUA, FEDERICA
BLUA, FEDERICA
SCIENZA E TECNOLOGIA DEL FARMACO
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor
2021-01-01 Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M.
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage
2023-01-01 Marini E.; Rolando B.; Sodano F.; Blua F.; Concina G.; Guglielmo S.; Lazzarato L.; Chegaev K.
Design and synthesis of encorafenib-based BRAF-V600E degraders
2022-01-01 Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Design and synthesis of SWIR emitters for optical imaging
2022-01-01 Federica Blua, Mariangela Boccalon, Barbara Rolando, Roberta Napolitano, Massimo Bertinaria
Design, synthesis and selection of INF200, a new non-sulfonylurea based NLRP3 inhibitor
2023-01-01 Federica Blua, Eleonora Gianquinto, Maria Concetta Granieri, Valentina Boscaro, Massimo Bertinaria
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation
2023-01-01 Gastaldi, Simone; Rocca, Carmine; Gianquinto, Eleonora; Granieri, Maria Concetta; Boscaro, Valentina; Blua, Federica; Rolando, Barbara; Marini, Elisabetta; Gallicchio, Margherita; De Bartolo, Anna; Romeo, Naomi; Mazza, Rosa; Fedele, Francesco; Pagliaro, Pasquale; Penna, Claudia; Spyrakis, Francesca; Bertinaria, Massimo; Angelone, Tommaso
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma
2024-01-01 Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M.
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold
2021-01-01 Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F. Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A. MacDonald, Massimo Bertinaria
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases
2019-01-01 Simone Gastaldi, Federica Blua, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein
2022-01-01 Marini, Elisabetta; Marino, Marco; Gionfriddo, Giulia; Maione, Federica; Pandini, Marta; Oddo, Daniele; Giorgis, Marta; Rolando, Barbara; Blua, Federica; Gastaldi, Simone; Marchiò, Serena; Kovachka, Sandra; Spyrakis, Francesca; Gianquinto, Eleonora; Di Nicolantonio, Federica; Bertinaria, Massimo
New inhibitors of NLRP3 inflammasome activation: pharmacological characterization in differentiated THP-1.
2022-01-01 Valentina Boscaro, Simone Gastaldi, Federica Blua, Massimo Bertinaria, Margherita Gallicchio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor | 2021 | Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M. | |
| Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage | 2023 | Marini E.; Rolando B.; Sodano F.; Blua F.; Concina G.; Guglielmo S.; Lazzarato L.; Chegaev K. | |
| Design and synthesis of encorafenib-based BRAF-V600E degraders | 2022 | Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria | |
| Design and synthesis of SWIR emitters for optical imaging | 2022 | Federica Blua, Mariangela Boccalon, Barbara Rolando, Roberta Napolitano, Massimo Bertinaria | |
| Design, synthesis and selection of INF200, a new non-sulfonylurea based NLRP3 inhibitor | 2023 | Federica Blua, Eleonora Gianquinto, Maria Concetta Granieri, Valentina Boscaro, Massimo Bertinaria | |
| Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation | 2023 | Gastaldi, Simone; Rocca, Carmine; Gianquinto, Eleonora; Granieri, Maria Concetta; Boscaro, Valentina; Blua, Federica; Rolando, Barbara; Marini, Elisabetta; Gallicchio, Margherita; De Bartolo, Anna; Romeo, Naomi; Mazza, Rosa; Fedele, Francesco; Pagliaro, Pasquale; Penna, Claudia; Spyrakis, Francesca; Bertinaria, Massimo; Angelone, Tommaso | |
| Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma | 2024 | Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M. | |
| In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold | 2021 | Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F. Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A. MacDonald, Massimo Bertinaria | |
| Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases | 2019 | Simone Gastaldi, Federica Blua, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria | |
| Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein | 2022 | Marini, Elisabetta; Marino, Marco; Gionfriddo, Giulia; Maione, Federica; Pandini, Marta; Oddo, Daniele; Giorgis, Marta; Rolando, Barbara; Blua, Federica; Gastaldi, Simone; Marchiò, Serena; Kovachka, Sandra; Spyrakis, Francesca; Gianquinto, Eleonora; Di Nicolantonio, Federica; Bertinaria, Massimo | |
| New inhibitors of NLRP3 inflammasome activation: pharmacological characterization in differentiated THP-1. | 2022 | Valentina Boscaro, Simone Gastaldi, Federica Blua, Massimo Bertinaria, Margherita Gallicchio |